Sage Therapeutics Inc (SAGE)
12.95
+0.06
(+0.47%)
USD |
NASDAQ |
Apr 23, 16:00
12.95
0.00 (0.00%)
After-Hours: 19:36
Sage Therapeutics Profit Margin (Quarterly): -41.95% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -41.95% |
| September 30, 2023 | -7.42K% |
| June 30, 2023 | -6.48K% |
| March 31, 2023 | -4.46K% |
| December 31, 2022 | -5.14K% |
| September 30, 2022 | -7.90K% |
| June 30, 2022 | -8.41K% |
| March 31, 2022 | -7.72K% |
| December 31, 2021 | -7.60K% |
| September 30, 2021 | -9.04K% |
| June 30, 2021 | -6.53K% |
| March 31, 2021 | -6.05K% |
| Date | Value |
|---|---|
| December 31, 2020 | 87.89% |
| September 30, 2020 | -6.45K% |
| June 30, 2020 | -12.52K% |
| March 31, 2020 | -5.54K% |
| December 31, 2019 | -8.60K% |
| September 30, 2019 | -5.04K% |
| June 30, 2019 | -19.27K% |
| March 31, 2019 | -35.14K% |
| December 31, 2018 | -58.02K% |
| September 30, 2018 | |
| June 30, 2018 | -18.86% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-19.27K%
Minimum
Jun 2019
87.89%
Maximum
Dec 2020
-7.06K%
Average
-6.53K%
Median
Jun 2021
Profit Margin (Quarterly) Benchmarks
| Biogen Inc | 10.46% |
| Perspective Therapeutics Inc | -- |
| Vanda Pharmaceuticals Inc | -5.30% |
| ADMA Biologics Inc | -23.88% |
| Finch Therapeutics Group Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -54.30% |
| Return on Assets | -49.30% |
| Return on Invested Capital | -54.30% |
| Gross Profit Margin (Quarterly) | 98.95% |
| Operating Margin (Quarterly) | -54.23% |
| Return on Net Operating Assets | -1.36K% |